Maintenance of beta-cell function and survival following islet isolation requires re-establishment of the islet-matrix relationship.
Islet transplantation is associated with a high rate of early graft failure, a problem that remains poorly understood. It is probable that the destruction of the islet microenvironment and loss of tropic support that occur during isolation lead to compromised survival. The purpose of this study was to determine the role of matrix-integrin interactions on beta-cell survival and function following islet isolation. Canine islets were obtained by conventional methods. Immediately after isolation, the peri-insular basement membrane (BM) was absent. The ability of islets maintained in suspension culture to attach to a collagen matrix declined progressively over 6 days. Attachment could be blocked by an arginine-glycine-aspartate (RGD) motif-presenting synthetic peptide, thereby implicating an integrin-mediated process. Characterization of cell surface integrins by immunocytochemistry (ICC) demonstrated that the expression of integrins alpha3, alpha5 and alphaV diminished during the culture period. This change was coincident with both a decrease in beta-cell function (proinsulin gene expression, islet insulin content and stimulated insulin release) and a rise in beta-cell death from apoptosis, as determined by in situ cell death detection (TUNEL) assay. These adverse events were prevented or delayed by exposure of islets to matrix proteins. In conclusion, routine islet isolation disrupts the cell-matrix relationship leading to a variety of structural and functional abnormalities, including apoptotic cell death. These alterations can be diminished by restoration of a culture microenvironment that includes matrix proteins.
Wang
R N
RN
Department of Surgery, McGill University, and Montreal General Hospital Research Institute, Montréal, Québec, Canada.
Rosenberg
L
L
D000818:Animals; D017209:Apoptosis; D002470:Cell Survival / Q000502:physiology; D004285:Dogs; D005109:Extracellular Matrix / Q000502:physiology*; D005260:Female; D005947:Glucose / Q000494:pharmacology; D007124:Immunoenzyme Techniques; D020287:In Situ Nick-End Labeling; D007328:Insulin / Q000378:metabolism; D016023:Integrins / Q000378:metabolism; D007515:Islets of Langerhans / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D016381:Islets of Langerhans Transplantation / Q000502:physiology*; D008297:Male
D007328:Insulin; D016023:Integrins; D005947:Glucose